Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 636–637 | Cite as

ASO Author Reflections: Biological Diversity of Histologic Subtypes

  • Audree B. Tadros
  • Monica MorrowEmail author
ASO Author Reflections



The preparation of this commentary was funded in part by NIH/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center.


Dr. Monica Morrow has received honoraria from Genomic Health and Roche.


  1. 1.
    Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRefGoogle Scholar
  2. 2.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.CrossRefGoogle Scholar
  3. 3.
    Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer. 1993;71:2507–14.CrossRefGoogle Scholar
  4. 4.
    Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, et al. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012;30:2218–26.CrossRefGoogle Scholar
  5. 5.
    Tadros AB, Wen HY, Morrow M. Breast cancers of special histologic subtypes are biologically diverse. Ann Surg Oncol. 2018;25:3158–64.CrossRefGoogle Scholar
  6. 6.
    Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med. 2015;373:2005–14.CrossRefGoogle Scholar
  7. 7.
    Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015;107(7):djv098.CrossRefGoogle Scholar
  8. 8.
    Afghahi A, Sledge GW Jr. Targeted therapy for cancer in the genomic era. Cancer J. 2015;21:294–8.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Breast Service, Department of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations